Zheng Quan Zhi Xing·2025-04-01 08:24Group 1 - The company, Shanghai Aladdin Biochemical Technology Co., Ltd., issued a total of 3.874 million convertible bonds, raising a total of RMB 387.4 million, with a net amount of RMB 373.38 million after deducting issuance costs [2][3] - The bonds have a maturity of six years, with an annual interest rate that increases from 0.4% in the first year to 3.0% in the sixth year [3][4] - The initial conversion price for the bonds is set at RMB 63.72 per share, which can be adjusted based on specific corporate actions [5][13] Group 2 - The company has provisions for adjusting the conversion price in case of stock dividends, capital increases, or other corporate actions that affect share capital [6][8] - If the stock price falls below 85% of the conversion price for 15 out of 30 consecutive trading days, the company can propose a downward adjustment of the conversion price, subject to shareholder approval [9][17] - The company has successfully adjusted the conversion price multiple times, with the latest adjustment setting it at RMB 16.17 per share effective from March 26, 2025 [14][18] Group 3 - The company has a credit rating of A+ for the convertible bonds, indicating a stable outlook [12] - The bonds are listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board, providing liquidity and visibility to investors [3][5] - The company is committed to maintaining investor rights and will closely monitor the bond's principal and interest repayment situation [18]